|
× |
 |
Effects of Adjunctive Metformin on Metabolic Traits in Nondiabetic Clozapine-Treated Patients With Schizophrenia and the Effect of Metformin Discontinuation on Body Weight: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Assessing the Efficacy of Desvenlafaxine for Improving Functioning and Well-Being Outcome Measures in Patients With Major Depressive Disorder: A Pooled Analysis of 9 Double-Blind, Placebo-Controlled, 8-Week Clinical Trials PDF |
$40.00 |
|
$40.00 |
|
× |
|
High False-Positive Rate of a Putative Biomarker Test to Aid in the Diagnosis of Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
|
